Edwards Lifesciences Corp (EW)

Mexico
Currency in MXN
1,544.00
+96.00(+6.63%)
Closed

EW Cash Flow Statement

Advanced Cash Flow Statement
Collapse All
Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa1,054.31,732.11,218.2895.8-
Cash from Operations Growth
Net Income
Depreciation & Amortisation, Total
Amortisation of Deferred Charges, Total
Other Non-Cash Items, Total
Change in Net Operating Assets
aa.aaaa.aaaa.aaaa.aaaa.aa-10.87%+64.29%-29.67%-26.47%-
aa.aaaa.aaaa.aaaa.aaaa.aa823.41,503.11,521.91,402.4-
aa.aaaa.aaaa.aaaa.aaaa.aa107.2134.8139.6144.9-
aa.aaaa.aaaa.aaaa.aaaa.aa-----
aa.aaaa.aaaa.aaaa.aaaa.aa81.5-51.1-21.9-125.2-
aa.aaaa.aaaa.aaaa.aaaa.aa42.2145.3-421.4-526.3-
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-531.1-1,722.5252.3173.8-
Cash from Investing Growth
Capital Expenditure
Sale of Property, Plant, and Equipment
Cash Acquisitions
Divestitures
Other Investing Activities
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-486.9-356.3-1,584.5-711-
Cash from Financing Growth
Total Debt Issued
Short Term Debt Issued, Total
Long-Term Debt Issued, Total
Total Debt Repaid
Short Term Debt Repaid, Total
Long-Term Debt Repaid, Total
Issuance of Common Stock
Repurchase of Common Stock
Issuance of Preferred Stock
Repurchase of Preferred Stock
Common & Preferred Stock Dividends Paid
Special Dividend Paid
Other Financing Activities
Foreign Exchange Rate Adjustments
Miscellaneous Cash Flow Adjustments
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa15.8-332.8-94.8375.4-
Beginning Cash Balance
Ending Cash Balance
Levered Free Cash Flow
Levered Free Cash Flow Growth
Free Cash Flow Yield
aa.aaaa.aaaa.aaaa.aaaa.aa1,167.41,195.6863.8768.6-
aa.aaaa.aaaa.aaaa.aaaa.aa1,183.2862.87691,144-
aa.aaaa.aaaa.aaaa.aaaa.aa373.751,008.96933.04751.03-
aa.aaaa.aaaa.aaaa.aaaa.aa-27.7%+169.96%-7.53%-19.51%-
aa.aaaa.aaaa.aaaa.aaaa.aa0.06%-0.11%0.08%-
* In Millions of USD (except for per share items)